Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
Zak M. Whiting, Jiazhen Yin, Sara M. de la Harpe, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 754-771
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Structural basis of selective cannabinoid CB2 receptor activation
Xiaoting Li, Hao Chang, Jara Bouma, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
CB2 receptor in the CNS: From immune and neuronal modulation to behavior
Wanda Grabon, Sylvain Rheims, Jonathon Smith, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 150, pp. 105226-105226
Open Access | Times Cited: 27
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists
Miroslav Kosar, Roman C. Sarott, David A. Sykes, et al.
ACS Central Science (2024) Vol. 10, Iss. 5, pp. 956-968
Open Access | Times Cited: 8
The intervention of cannabinoid receptor in chronic and acute kidney disease animal models: a systematic review and meta-analysis
Zihao Zhao, Qianqian Yan, Junwei Xie, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
DeLA-DrugSelf: Empowering multi-objective de novo design through SELFIES molecular representation
Domenico Alberga, G. Lamanna, Giovanni Graziano, et al.
Computers in Biology and Medicine (2024) Vol. 175, pp. 108486-108486
Open Access | Times Cited: 6
Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke
Iu Raïch, Jaume Lillo, Rafael Rivas‐Santisteban, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6708-6708
Open Access | Times Cited: 4
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
Siyuan Shen, Chao Wu, Zhiqian Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
The Effects of Indirect and Direct Modulation of Endocannabinoid System Function on Anxiety-Related Behavior in Mice Assessed in the Elevated Plus Maze Test
Marta Kruk-Słomka, Agnieszka Dzik, Grażyna Biała
Molecules (2025) Vol. 30, Iss. 4, pp. 867-867
Open Access
Metabolomic Characterization and Bioinformatic Studies of Bioactive Compounds in Two Varieties of Psidium guajava L. Leaf by GC–MS Analysis
Ana Victoria Valdivia-Padilla, Ashutosh Sharma, Jorge A. Zegbe, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2530-2530
Open Access
Distinct activation mechanisms regulate subtype selectivity of Cannabinoid receptors
Soumajit Dutta, Diwakar Shukla
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 11
Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia In Vitro
A. P. Young, Anna-Maria Szczesniak, Karolynn Hsu, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 5, pp. 1348-1363
Open Access | Times Cited: 4
The progress of small molecules against cannabinoid 2 receptor (CB2R)
Qinying Zhang, Ying Zhao, Jianan Wu, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107075-107075
Closed Access | Times Cited: 3
Identification of Novel CB2 Ligands through Virtual Screening and In Vitro Evaluation
Adam Stasiulewicz, Anna Leśniak, Magdalena Bujalska‐Zadrożny, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 3, pp. 1012-1027
Open Access | Times Cited: 8
Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation
Jiayi Yuan, Bo Ram Yang, Guanyu Hou, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103615-103615
Open Access | Times Cited: 8
Cannabinoid CB2 receptor orthologues; in vitro function and perspectives for preclinical to clinical translation
Emma R. Carruthers, Natasha L. Grimsey
British Journal of Pharmacology (2023) Vol. 181, Iss. 14, pp. 2247-2269
Open Access | Times Cited: 8
Discovery and development of macrocyclic peptide modulators of the cannabinoid 2 receptor
Nataša Tomašević, Fabiola Susanna Emser, Jasmin Gattringer, et al.
(2024)
Open Access | Times Cited: 2
Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations
Tahira Foyzun, M.J. Whiting, Kate K. Velasco, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 15, pp. 2391-2412
Open Access | Times Cited: 2
In vitro characterization of the pyrazole-carrying synthetic cannabinoid receptor agonist 5F-3,5-AB-PFUPPYCA and its structural analogs
Marie H. Deventer, Caitlyn Norman, Robert L. Reid, et al.
Forensic Science International (2023) Vol. 343, pp. 111565-111565
Open Access | Times Cited: 5
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)
Giovanni Graziano, Pietro Delre, Francesca Carofiglio, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115109-115109
Closed Access | Times Cited: 5
Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias
Raahul Sharma, Sameek Singh, Zak M. Whiting, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6406-6406
Open Access | Times Cited: 5
Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity
Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela Carmen Ababei, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1667-1667
Open Access | Times Cited: 5
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor
Monica Patel, Natasha L. Grimsey, Samuel D. Banister, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 5
The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: soft and hard vanilloid/cannabinoid modulators
Angela Lamberti, M. Teresa Serafini, Silvio Aprile, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116845-116845
Open Access | Times Cited: 1
Trifluoro-Icaritin Ameliorates Neuroinflammation Against Complete Freund’s Adjuvant-Induced Microglial Activation by Improving CB2 Receptor-Mediated IL-10/β-endorphin Signaling in the Spinal Cord of Rats
Guangsen Liu, Dandan Jia, Weiwei Li, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Closed Access | Times Cited: 1
The cannabinoid CB 2 receptor positive allosteric modulator EC21a exhibits complicated pharmacology in vitro
Aidong Qi, Xueqing Han, Marc Quitalig, et al.
Journal of Receptors and Signal Transduction (2024), pp. 1-9
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top